Addiction Disorders 4 - Clinical (2)

[P399] PHARMACOVIGILANCE SIGNALS OF SEMAGLUTIDE AND OTHER GLP-1 RECEPTOR AGONISTS: AN ANALYSIS OF THE FOOD AND DRUG ADMINISTRATION (FDA) ADVERSE EVENTS REPORTING SYSTEM (FAERS) DATASET

STEFANIA CHIAPPINI¹, GIACOMO D'ANDREA², *CLARA CAVALLOTTO², ALESSIO MOSCA², FRANCESCO DI CARLO², MAURO PETTORRUSO², GIOVANNI MARTINOTTI², FABRIZIO SCHIFANO³ (1. UniCamillus, 2. Department of Neuroscience, Imaging and Clinical Science, University G. D'Annunzio, Chieti, Italy, 3. Department of Clinical and Pharmaceutical Sciences, University of Hertfordshire, Hatfeld, UK )

Keywords:semaglutide, drug misuse, drug abuse, pharmacovigilance, image- and performance-enhancing drugs (IPEDs)